Update on vascular disrupting agents for cancer therapy

Author： Korpanty Grzegorz   Brekken Rolf A  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.4, 2011-07, pp. : 403-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of vascular disrupting agents as a concomitant anti-tumour modality with radiation

By  

Journal of Radiotherapy in Practice, Vol. 12, Iss. 3, 2013-05 ,pp. : 255-262

Cambridge University Press

Access to resources Recommend Favorite

Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement

By Ngwa Wilfred   Makrigiorgos G Mike   Berbeco Ross I  

Physics in Medicine and Biology, Vol. 55, Iss. 21, 2010-11 ,pp. : 6533-6548

IOP Publishing

Access to resources Recommend Favorite

Chromatin Remodeling Agents for Cancer Therapy

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 3, 2008-09 ,pp. : 192-203

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced breast cancer: an update and controversies on diagnosis and therapy

By Nicolini A.   Carpi A.  

Biomedicine and Pharmacotherapy, Vol. 57, Iss. 10, 2003-12 ,pp. : 439-446

Elsevier

Access to resources Recommend Favorite

Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 10, 2015-10 ,pp. : 1873-1883

John Wiley & Sons Inc

Access to resources Recommend Favorite